RANBP2 as modifier of the PTEN/IGF pathway and methods of use

Details for Australian Patent Application No. 2004241436 (hide)

Owner Exelixis, Inc.

Inventors Ollmann, Michael Martin; Lickteig, Kim; Song, Chunyan

Agent Davies Collison Cave

Pub. Number AU-A-2004241436

PCT Pub. Number WO2004/104171

Priority 60/470,766 14.05.03 US

Filing date 13 May 2004

Wipo publication date 2 December 2004

International Classifications

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/104171 Priority application(s): WO2004/104171

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004241441-Interference and noise estimation in an OFDM system

2004241421-Methods and compositions for the production of adenoviral vectors